Effects of propranolol on heart rate and development in Japanese medaka (Oryzias latipes) and zebrafish (Danio rerio)

Antkiewicz, 2005, Heart malformation is an early response to TCDD in embryonic zebrafish, Toxicological Sciences, 84, 368, 10.1093/toxsci/kfi073 Barret, 1968, The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias, British Journal of Pharmacology, 34, 43, 10.1111/j.1476-5381.1968.tb07949.x Calabrese, 2004, Hormesis: a revolution in toxicology, risk assessment and medicine, EMBO, 5, S37, 10.1038/sj.embor.7400222 Cheng, 2000, Cellular and molecular basis of cadmium-induced deformities in zebrafish embryos, Environmental Toxicology and Chemistry, 19, 3024, 10.1002/etc.5620191223 Cibrian-Uhalte, 2007, Involvement of zebrafish Na+K+ATPase in myocardial cell junction maintenance, Journal of Cell Biology, 176, 223, 10.1083/jcb.200606116 Fraysse, 2006, Development of a zebrafish 4-day embryo-larval bioassay to assess toxicity of chemicals, Ecotoxicology and Environmental Safety, 63, 253, 10.1016/j.ecoenv.2004.10.015 Gamperl, 1994, β-Adrenoreceptors in the trout (Oncorhynchus mykiss) heart: characterisation, quantification and effects of repeated catecholamine exposure, General and Comparative Endocrinology, 95, 227, 10.1006/gcen.1994.1123 Giltrow, 2009, Chronic effects and plasma concentrations of the B-blocker propranolol in fathead minnows (Pimephales promelas), Aquatic Toxicology, 95, 195, 10.1016/j.aquatox.2009.09.002 Goldstone, 2010, Identification and developmental expression of the full complement of cytochrome P450 genes in zebrafish, BMC Genomics, 11, 643, 10.1186/1471-2164-11-643 Gomez, 2010, The influence of gill and liver metabolism on the predicted bioconcentration of three pharmaceuticals in fish, Chemosphere, 81, 1189, 10.1016/j.chemosphere.2010.09.043 Huggett, 2002, Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (B-blockers) on aquatic organisms, Archives of Environmental Contamination and Toxicology, 43, 229, 10.1007/s00244-002-1182-7 Huggett, 2003, Determination of beta-adrenergic receptor blocking pharmaceuticals in United States wastewater effluent, Environmental Pollution, 121, 199, 10.1016/S0269-7491(02)00226-9 Incardona, 2004, Defects in cardiac function precede morphological abnormalities in fish embryos exposed to polycyclic aromatic hydrocarbons, Toxicology and Applied Pharmacology, 196, 191, 10.1016/j.taap.2003.11.026 Iwamatsu, 2004, Stages of normal development in the medaka Oryzias latipes, Mechanisms of Development, 121, 605, 10.1016/j.mod.2004.03.012 Jones, 2010, Oxidative and conjugative xenobiotic metabolism in zebrafish larvae in vivo, Zebrafish, 7, 23, 10.1089/zeb.2009.0630 Kawasaki, 2008, Pharmacological characterization of isoproterenol-treated medaka fish, Pharmacological Research, 58, 348, 10.1016/j.phrs.2008.09.011 Keen, 1993, Thermal acclimation alters both adrenergic sensitivity and adrenoreceptor density in cardiac tissue of rainbow trout, Journal of Experimental Biology, 181, 27, 10.1242/jeb.181.1.27 Kimmel, 1995, Stages of embryonic development of the zebrafish, Developmental Dynamics: an Official Publication of the American Association of Anatomists, 203, 253, 10.1002/aja.1002030302 Klaverkamp, 1974, Autonomic receptors in isolated rainbow trout vasculature, European Journal of Pharmacology, 28, 25, 10.1016/0014-2999(74)90108-3 Langenbacher, 2011, The PAF1 complex differentially regulates cardiomyocyte specification, Developments in Biologicals, 353, 19, 10.1016/j.ydbio.2011.02.011 Mehvar, 2001, Stereospecific pharmacokinetics and pharmacodynamics of B-adrenergic blockers in humans, Journal of Pharmaceutical Sciences., 4, 185 Nickerson, 2001, A putative β2-adrenoreceptor from the rainbow trout, European Journal of Biochemistry, 268, 6465, 10.1046/j.0014-2956.2001.02600.x Nikinmaa, 2003, β3-Adrenergic receptors-studies on trout reveal ancient evolutionary origins and functions distinct from the thermogenic response, American Journal of Physiology, 285, R515 Owen, 2007, Comparative physiology, pharmacology and toxicology of beta-blockers: mammals versus fish, Aquatic Toxicology, 82, 145, 10.1016/j.aquatox.2007.02.007 Owen, 2009, Uptake of propranolol, a cardiovascular pharmaceutical, from water into fish plasma and its effects on growth and organ biometry, Aquatic Toxicology, 93, 217, 10.1016/j.aquatox.2009.05.009 Schlenk, 2008, Biotransformation in Fishes, 153 Steele, 2011, In vivo and in vitro assessment of cardiac-adrenergic receptors in larval zebrafish (Danio rerio), Journal of Experimental Biology, 214, 1445, 10.1242/jeb.052803 Tabacova, 2003, Atenolol developmental toxicity: animal-to-human comparisons, Birth Defects Research. Part A, Clinical and Molecular Teratology, 67, 181, 10.1002/bdra.10011 Tong, 1999, Na+ channel and Na+–K+ ATPase involvement in norepinephrine- and veratridine-stimulated metabolism in perfused rat hind limb, Canadian Journal of Physiology and Pharmacology, 77, 350, 10.1139/y99-036 Varga, 1999, Nonspecific membrane effects of CH-103: hydrophobicity, surface activity and membrane fluidity studies in comparison with propranolol and practolol, Pharmazie, 54, 380 Wang, 2009, Zebrafish β-adrenergic receptor mRNA expression and control of pigmentation, Gene, 446, 18, 10.1016/j.gene.2009.06.005 Wiener, 1985, Drugs that inhibit adrenergic nerves and block adrenergic receptors, 181 Xiao, 2008, Determination of propranolol in dog plasma by HPLC method, Asian Journal of Pharmacodynamics and Pharmacokinetics, 8, 153